Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00001839 | A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | completed | Phase 2 | 182 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001869 | Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM) | completed | — | 400 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 |
| clinicaltrials |
| NCT00001944 | Vinorelbine and XR9576 to Treat Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00004988 | Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005660 | The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases | completed | — | 130 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005910 | Laparoscopy to Remove Pancreatic Tumors (Insulinomas) | completed | N/A | 23 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005926 | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00006155 | SU5416 and Carboplatin to Treat Ovarian Cancer | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00017927 | A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome | completed | Phase 3 | 10 | National Institute of Dental and Craniofacial Research (NIDCR)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00022919 | Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods | completed | — | 150 | National Human Genome Research Institute (NHGRI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026728 | Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States | completed | — | 20,169 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026910 | Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma | completed | — | 200 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026949 | Study of Etoposide in Breast Cancer Patients | completed | — | 33 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026962 | Effects of Raloxifene on Hormone Levels | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00047918 | Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing | completed | — | 100 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00055380 | Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients | completed | Phase 1 | 120 | National Institute of Dental and Craniofacial Research (NIDCR)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00059020 | The Role of Gene Changes in Brain Tumor Formation and Growth | completed | — | 344 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00071344 | Analysis of Brain Metastasis in Patients With Lung Cancer | completed | — | 78 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00075166 | Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors | completed | Phase 4 | 130 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00080574 | The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients | completed | Phase 2 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00340717 | Markers for Early Detection of Prostate Cancer | completed | — | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00341107 | Physicians Survey on Genetic Testing | completed | — | 1,350 | National Cancer Institute (NCI)NIH | 0 | Mar 4, 2008 | clinicaltrials |
| NCT00278070 | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | completed | Phase 2 | — | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00398970 | Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer. | completed | N/A | 240 | Haukeland University HospitalOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00066092 | Pegfilgrastim PBPC Mobilization Study | completed | Phase 2 | 41 | AmgenINDUSTRY | 0 | Feb 28, 2008 | clinicaltrials |
| NCT00111137 | Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy | completed | Phase 3 | 718 | AmgenINDUSTRY | 0 | Feb 28, 2008 | clinicaltrials |
| NCT00619814 | Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT?(DCBE) | completed | N/A | 50 | VA Caribbean Healthcare SystemFED | 0 | Feb 21, 2008 | clinicaltrials |
| NCT00610844 | Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors | completed | Phase 2 | 9 | University Hospital TuebingenOTHER | 1 | Feb 20, 2008 | clinicaltrials |
| NCT00394446 | Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors | completed | Phase 1 | 48 | Myrexis Inc.INDUSTRY | 1 | Feb 13, 2008 | clinicaltrials |
| NCT00051974 | Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 155 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00051987 | Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma | completed | Phase 2 | 175 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00063713 | VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma | completed | Phase 2 | 152 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00085696 | VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma | completed | Phase 2 | 66 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00257114 | Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability | completed | Phase 4 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00274248 | MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia | completed | Phase 1 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00611754 | Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 15 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00612495 | Endometrial Cancer - LOHP Alone and With 5FU | completed | Phase 2 | 31 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00001535 | Twins Study of Gene Therapy for HIV Infection | completed | Phase 1 | 48 | National Human Genome Research Institute (NHGRI)NIH | 1 | Feb 8, 2008 | clinicaltrials |
| NCT00579852 | Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer Tumors | completed | — | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2008 | clinicaltrials |
| NCT00095225 | A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) | completed | Phase 2 | 122 | Genentech, Inc.INDUSTRY | 1 | Jan 29, 2008 | clinicaltrials |
| NCT00076531 | Clinical Trial for Prostate Cancer | completed | Phase 3 | — | Oakwood Laboratories, LLCINDUSTRY | 0 | Jan 28, 2008 | clinicaltrials |
| NCT00079794 | Iscar for Supplemental Care in Stage IV Lung Cancer | completed | Phase 2 | 36 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00590213 | Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX(COMART) | completed | Phase 4 | 125 | AstraZenecaINDUSTRY | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00600522 | Alternative Surgical Policy for Central Liver Tumors | completed | — | 15 | University of MilanOTHER | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00601016 | A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy | completed | Phase 2 | 18 | St. Justine's HospitalOTHER | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00259818 | Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors | completed | Phase 1 | 30 | Erimos PharmaceuticalsINDUSTRY | 1 | Jan 24, 2008 | clinicaltrials |
| NCT00599937 | APL93: Timing of CxT and Role of Maintenance | completed | Phase 3 | 576 | Groupe d'etude et de travail sur les leucemies aigues promyelocytairesOTHER | 0 | Jan 24, 2008 | clinicaltrials |
| NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | completed | Phase 3 | 478 | Hellenic Oncology Research GroupOTHER | 1 | Jan 21, 2008 | clinicaltrials |
| NCT00087841 | Self-Hypnotic Relaxation Therapy During Invasive Procedures | completed | Phase 2 | 390 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 17, 2008 | clinicaltrials |
| NCT00066196 | Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma | completed | Phase 2 | 110 | MedImmune LLCINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Mar 4, 2008source: clinicaltrials